hydroxyurea has been researched along with Parkinson Disease in 1 studies
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Benserazide is used in the treatment of Parkinson's disease and was noticed to induce gamma globin in preclinical models." | 1.62 | Benserazide as a potential novel fetal hemoglobin inducer: an observational study in non-carriers of hemoglobin disorders. ( Costa, FF; de Azevedo, PC; Fertrin, KY; Leonardo, DP; Olops, L; Piovesana, LG; Santos, MEHP; Tavares, AHJ; Vendrame, F, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Santos, MEHP | 1 |
| Olops, L | 1 |
| Vendrame, F | 1 |
| Tavares, AHJ | 1 |
| Leonardo, DP | 1 |
| de Azevedo, PC | 1 |
| Piovesana, LG | 1 |
| Costa, FF | 1 |
| Fertrin, KY | 1 |
1 other study available for hydroxyurea and Parkinson Disease
| Article | Year |
|---|---|
Benserazide as a potential novel fetal hemoglobin inducer: an observational study in non-carriers of hemoglobin disorders.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Sickle Cell; Antiparkinson Agents; Antisickling Agents; Bens | 2021 |